Seymour MT, Brown SR, Middleton G, et al. Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild -type, fluorouracil- resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial. The Lancet Oncology.